| Characteristic | Overall N = 2391 |
0 N = 1951 |
1 N = 441 |
p-value2 |
|---|---|---|---|---|
| Sex | >0.9 | |||
| Male | 0 (0%) | 0 (0%) | 0 (0%) | |
| Female | 238 (100%) | 194 (100%) | 44 (100%) | |
| Age (years) | 10 (6, 16) | 9 (6, 16) | 10 (6, 17) | >0.9 |
| age_group | 0.5 | |||
| <5 years | 40 (17%) | 35 (18%) | 5 (11%) | |
| 5-14 years | 125 (53%) | 100 (52%) | 25 (57%) | |
| >=15 years | 70 (30%) | 56 (29%) | 14 (32%) | |
| country | <0.001 | |||
| Burkina Faso | 10 (4.2%) | 10 (5.1%) | 0 (0%) | |
| DRC | 103 (43%) | 73 (37%) | 30 (68%) | |
| Ethiopia | 6 (2.5%) | 6 (3.1%) | 0 (0%) | |
| Ghana | 35 (15%) | 28 (14%) | 7 (16%) | |
| Madagascar | 40 (17%) | 40 (21%) | 0 (0%) | |
| Nigeria | 45 (19%) | 38 (19%) | 7 (16%) | |
| MDR | 30 (17%) | 26 (18%) | 4 (13%) | 0.5 |
| Prior Medication | 190 (80%) | 149 (77%) | 41 (93%) | 0.015 |
| 1 n (%); Median (Q1, Q3) | ||||
| 2 Fisher’s exact test; Wilcoxon rank sum test; Pearson’s Chi-squared test | ||||